BOLT vs BR · rev $7.7M vs P/E 16, rev $6.89B
Bolt Biotherapeutics (BOLT) versus Broadridge Financial Solutions Inc (BR) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
BOLT currently screens at market cap $11.3M. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Not investment advice. Open the BOLT and BR stock pages for the full models.
Not investment advice.